Executive Committee
Charles Sanders, M.D. (Chairman)
Former Chairman and CEO, Glaxo, Inc. and Chairman, Foundation for NIH
James F. Battey, Jr., M.D., Ph.D.
Director, National Institute on Deafness and Other Communication Disorders
ShaAvhrée Buckman, M.D., Ph.D., F.A.A.P.
Director, Office of Translational Sciences, Food and Drug Administration
Gary Herman, M.D.
Vice President, Early Stage Development (ESD), Merck Research Laboratories
Thomas Insel, M.D.
Director, National Institute of Mental Health, National Institutes of Health
Douglas Lowy, M.D.
Deputy Director, National Cancer Institute
Garry Neil, M.D.
Corporate Vice President, Corporate Office of Science and Technology (COSAT), Johnson & Johnson
Steven Paul, M.D.
Director, Helen and Robert Appel Institute for Alzheimer’s Research, Weill Cornell Medical College and Senior Advisor, Third Rock Ventures; Member, Foundation for NIH Board of Directors
Sara Radcliffe, M.P.H.
Executive Vice President, Health, Biotechnology Industry Organization
Jeffrey E. Shuren, M.D., J.D.
Director, Center for Devices and Radiological Health, Food and Drug Administration
Ellen Sigal, Ph.D.
Founder and Chairperson, Friends of Cancer Research and Member, Foundation for NIH Board of Directors
Janet Woodcock, M.D.
Director, Center for Drug Evaluation and Research, Food and Drug Administration
Mary Woolley
President and Chief Executive Officer, Research!America
